“Embedded BQLs” [NCA / SHAM]

posted by mittyri – Russia, 2016-03-21 22:17  – Posting: # 16124
Views: 3,138

Hi arl_stat,

It was discussed on the forum, I would recommend you to read these threads: BLQ values in Winnonlin, ANVISA's POV on "triangulation points", LLOQ/2 for BQLs not suggested.

In a nutshell:
  1. You should unambigously state in the Protocol how to deal with these situations.
  2. If you didn't mention it in the Protocol you should find your appropriate SOP.
  3. You have at least 3 options:
    1. Interpolate this value (linear or logarithmic depending on stated algo of AUC calculation),
    2. LLOQ/2 (may be not a best idea)
    3. Deal it as zero.

Kind regards,

Complete thread:

 Admin contact
20,250 posts in 4,262 threads, 1,398 registered users;
online 19 (0 registered, 19 guests [including 4 identified bots]).
Forum time (Europe/Vienna): 19:23 CET

No written law has ever been more binding than
unwritten custom supported by popular opinion.    Carrie Chapman Catt

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz